CHDI Management

CHDI Management is a non-profit biomedical research organization exclusively dedicated to collaboratively developing therapeutics that substantially improve the lives of those affected by Huntington's disease. Operating as a virtual biotech, the organization does not own its own laboratories but instead partners with academic and industrial collaborators worldwide to bridge the gap between academic discovery and pharmaceutical development. CHDI manages a diverse portfolio of research projects, ranging from basic target identification and validation to clinical trial execution. By providing scientific expertise, financial resources, and specialized research tools, CHDI accelerates the drug discovery process for Huntington's disease. The organization also oversees large-scale clinical initiatives like Enroll-HD, a global observational study designed to facilitate clinical trial recruitment and provide longitudinal data for research. Their unique model focuses on de-risking therapeutic targets to encourage investment and participation from the broader pharmaceutical industry.